Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein

OBJECTIVE: The recent availability of novel antiviral drugs has raised new hope for a more effective treatment of hepatitis C virus (HCV) infection and its severe sequelae. However, in the case of non-responding or relapsing patients, alternative strategies are needed. To this end we have used chime...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Gut
Main Authors: Sautto, Giuseppe A, Wisskirchen, Karin, Clementi, Nicola, Castelli, Matteo, Diotti, Roberta A, Graf, Julia, Clementi, Massimo, Burioni, Roberto, Protzer, Ulrike, Mancini, Nicasio
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2016
Teme:
Hepatology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4789830/
https://ncbi.nlm.nih.gov/pubmed/25661083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2014-308316
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki